<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03559595</url>
  </required_header>
  <id_info>
    <org_study_id>ULouisville</org_study_id>
    <nct_id>NCT03559595</nct_id>
  </id_info>
  <brief_title>Increasing PrEP Among African Americans in Louisville KY</brief_title>
  <official_title>Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure
      prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African
      Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise
      awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe
      PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to
      PrEP services.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PrEP uptake</measure>
    <time_frame>12 months</time_frame>
    <description>Reported use of PrEP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PrEP intentions</measure>
    <time_frame>12 months</time_frame>
    <description>Intention to use PrEP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PrEP prescription</measure>
    <time_frame>12 months</time_frame>
    <description>Prescription of PrEP to eligible individuals by medical personnel</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>HIV/AIDS PREVENTION</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All study participants will be exposed to the intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Project Prevent</intervention_name>
    <description>The Project Prevent intervention entails 1) a media campaign to raise PrEP awareness, 2) geographically targeted education initiatives with medical personnel to increase access to consumers, and 3) programming with AIDS service organizations to improve service delivery around PrEP.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between ages 18-29 years old

          -  Self-identifies as African American or Black

          -  Resident of Louisville, KY

          -  Member of a priority group for PrEP HIV prevention (Men who have sex with men, people
             who inject drugs, trans women, high risk heterosexuals, people in serodiscordant
             relationships).

          -  Not diagnosed with HIV

        Exclusion Criteria:

          -  Older than 29 and younger than 18 years old

          -  Does not identify as African American or Black

          -  Does not reside in Louisville, KY

          -  Not a member of a priority group

          -  Diagnosed with HIV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Toya Northington</last_name>
    <phone>502-852-1908</phone>
    <email>Toya.northington@louisville.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toya Northington</last_name>
      <email>toya.northington@louisville.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>June 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2018</study_first_posted>
  <last_update_submitted>June 5, 2018</last_update_submitted>
  <last_update_submitted_qc>June 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Jelani Kerr</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

